Literature DB >> 10935473

Lack of homozygously inactivated p73 in single-copy MYCN primary neuroblastomas and neuroblastoma cell lines.

X T Kong1, V A Valentine, S T Rowe, M B Valentine, S T Ragsdale, B G Jones, D A Wilkinson, G M Brodeur, S L Cohn, A T Look.   

Abstract

We examined 18 neuroblastoma cell lines and 32 primary single-copy MYCN tumor specimens to determine whether mutations of p73, a novel p53-related gene located in chromosome band 1p36.33, contribute to the genesis or progression of childhood neuroblastoma. By fluorescence in situ hybridization, 16 of the 18 cell lines, but only 3 of the 32 primary tumors, had evidence of a deleted p73 allele. Sequence analysis of the p73 coding region in the mRNAs expressed by these cell lines and tumors did not reveal inactivating mutations, suggesting that p73 is not homozygously inactivated in neuroblastoma. However, several novel splice forms of p73 mRNAs were identified, including one without exon 11 that predominated in multiple MYCN-amplified cell lines. Its encoded p73 protein differed from other splice forms in that the C-terminus was derived from an alternative reading frame. Further study of the functional properties of the protein encoded by this splice form of p73 will be needed to determine whether it contributes to the pathogenesis of childhood neuroblastoma with MYCN gene amplification.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10935473      PMCID: PMC1716055          DOI: 10.1038/sj.neo.7900010

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  35 in total

1.  Chromosome 1 interphase-cytogenetics in 32 primary neuroblastomas of different clinical stages.

Authors:  H Christiansen; J Schestag; W Bielke; B Schütz; G Rust; R Engel; E Beniers; N M Christiansen; F Lampert
Journal:  Prog Clin Biol Res       Date:  1991

2.  Detection of N-myc oncogene expression in human neuroblastoma by in situ hybridization and blot analysis: relationship to clinical outcome.

Authors:  E F Grady-Leopardi; M Schwab; A R Ablin; W Rosenau
Journal:  Cancer Res       Date:  1986-06       Impact factor: 12.701

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  N-myc oncogene amplification and prognostic factors of neuroblastoma in children.

Authors:  A Nakagawara; K Ikeda; T Tsuda; K Higashi
Journal:  J Pediatr Surg       Date:  1987-10       Impact factor: 2.545

5.  Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas.

Authors:  R C Seeger; G M Brodeur; H Sather; A Dalton; S E Siegel; K Y Wong; D Hammond
Journal:  N Engl J Med       Date:  1985-10-31       Impact factor: 91.245

6.  Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.

Authors:  G M Brodeur; R C Seeger; M Schwab; H E Varmus; J M Bishop
Journal:  Science       Date:  1984-06-08       Impact factor: 47.728

7.  Analysis of N-myc amplification in relation to disease stage and histologic types in human neuroblastomas.

Authors:  T Tsuda; M Obara; H Hirano; S Gotoh; S Kubomura; K Higashi; A Kuroiwa; A Nakagawara; N Nagahara; K Shimizu
Journal:  Cancer       Date:  1987-08-15       Impact factor: 6.860

8.  Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour.

Authors:  M Schwab; K Alitalo; K H Klempnauer; H E Varmus; J M Bishop; F Gilbert; G Brodeur; M Goldstein; J Trent
Journal:  Nature       Date:  1983 Sep 15-21       Impact factor: 49.962

9.  Statistical analysis of cytogenetic abnormalities in human cancer cells.

Authors:  G M Brodeur; A A Tsiatis; D L Williams; F W Luthardt; A A Green
Journal:  Cancer Genet Cytogenet       Date:  1982-10

10.  Cytogenetic features of human neuroblastomas and cell lines.

Authors:  G M Brodeur; A A Green; F A Hayes; K J Williams; D L Williams; A A Tsiatis
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

View more
  5 in total

1.  Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains.

Authors:  Pamela Ghioni; Fabrizio Bolognese; Pascal H G Duijf; Hans Van Bokhoven; Roberto Mantovani; Luisa Guerrini
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

Review 2.  Interplay between the p53 tumor suppressor protein family and Cdk5: novel therapeutic approaches for the treatment of neurodegenerative diseases using selective Cdk inhibitors.

Authors:  Gerald Schmid; Joanna B Strosznajder; Józefa Wesierska-Gadek
Journal:  Mol Neurobiol       Date:  2006-08       Impact factor: 5.590

3.  BUB3 that dissociates from BUB1 activates caspase-independent mitotic death (CIMD).

Authors:  Y Niikura; H Ogi; K Kikuchi; K Kitagawa
Journal:  Cell Death Differ       Date:  2010-01-08       Impact factor: 15.828

4.  The MYCN oncogene is a direct target of miR-34a.

Authors:  J S Wei; Y K Song; S Durinck; Q-R Chen; A T C Cheuk; P Tsang; Q Zhang; C J Thiele; A Slack; J Shohet; J Khan
Journal:  Oncogene       Date:  2008-05-26       Impact factor: 9.867

5.  N-myc modulates expression of p73 in neuroblastoma.

Authors:  Xiaoxiang Zhu; Katharina Wimmer; Rork Kuick; Barbara J Lamb; Stephanie Motyka; Rama Jasty; Valerie P Castle; Samir M Hanash
Journal:  Neoplasia       Date:  2002 Sep-Oct       Impact factor: 5.715

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.